Pfizer Q1 Results 2027: PAT Rises 6.6% YoY; Revenue Grows 8.3%
Pfizer delivered steady growth in Q1 FY27 as higher revenue and improved operating margins supported an increase in profitability during the quarter.
Pfizer Q1 Results FY2027: Pfizer reported a healthy Q1 FY27 performance with revenue from operations rising 8.31% YoY to ₹653.17 crore. EBITDA increased 17.87% with margin expansion, while profit after tax grew 6.61% YoY to ₹204.42 crore.
Pfizer Q1 Results FY2027: On 28 July, Pfizer reported its financial performance for the first quarter of FY27. Revenue from operations increased 8.31% year-on-year to ₹653.17 crore, while Profit After Tax (PAT) rose 6.61% YoY to ₹204.42 crore.
Just after the results, Pfizer share price is up 0.02% at the time of writing. Pfizer stock is down 4.29% year-to-date and down 11.24% in one year from 28 July 2025 to 28 July 2026.
As of 28 July, 3:30 PM
READ THIS ALSO: Ambuja Cements Q1 Results 2027
Pfizer Q1 FY27 Results Highlights
-
Revenue from Operations increased to ₹653.17 crore, up 8.31% YoY from ₹603.05 crore. Compared with ₹629.23 crore in Q4 FY26, revenue increased 3.80% QoQ.
-
Total Revenue stood at ₹698.01 crore in Q1 FY27, registering a 4.15% YoY increase from ₹670.22 crore in Q1 FY26. Compared with ₹669.95 crore in Q4 FY26, total revenue increased 4.19% QoQ.
-
EBITDA (Excluding Other Income) stood at ₹247.56 crore, registering 17.87% YoY growth from ₹210.02 crore. Compared with ₹235.95 crore in Q4 FY26, EBITDA increased 4.92% QoQ.
-
EBITDA Margin stood at 37.90%, compared with 34.83% in Q1 FY26 and 37.50% in Q4 FY26, improving by 3.08 percentage points YoY and by 0.40 percentage points QoQ.
-
Profit After Tax (PAT) stood at ₹204.42 crore, rising 6.61% YoY from ₹191.75 crore. Compared with ₹199.82 crore in Q4 FY26, PAT increased 2.30% QoQ.
-
PAT Margin stood at 31.30%, compared with 31.80% in Q1 FY26 and 31.76% in Q4 FY26, declining by 0.50 percentage points YoY and by 0.46 percentage points QoQ.
|
Metric |
Q1 FY27 |
Q4 FY26 |
QoQ % |
Q1 FY26 |
YoY % |
|---|---|---|---|---|---|
|
Revenue from Operations (₹ Cr) |
653.17 |
629.23 |
3.80% |
603.05 |
8.31% |
|
Total Revenue (₹ Cr) |
698.01 |
669.95 |
4.19% |
670.22 |
4.15% |
|
EBITDA (Ex. Other Income) (₹ Cr) |
247.56 |
235.95 |
4.92% |
210.02 |
17.87% |
|
EBITDA Margin |
37.90% |
37.50% |
0.40% |
34.83% |
3.08% |
|
PAT (₹ Cr) |
204.42 |
199.82 |
2.30% |
191.75 |
6.61% |
|
PAT Margin |
31.30% |
31.76% |
-0.46% |
31.80% |
-0.50% |
|
EPS (₹) |
44.69 |
43.68 |
2.31% |
41.91 |
6.63% |
Source: Pfizer Q1 FY27 Financial Results.